Security key
71716E105
Pharming Group N.V. - Ordinary Shares / American Depositary Shares (PHAR)
CUSIP: 71716E105
Q4 2025 13F Holders as of 31 Dec 2025
- Security type / class
- Equity / Ordinary Shares / American Depositary Shares
- Total 13F shares
- 140,452
- Total 13F value
- $2,481,786
- Share change
- +67,938
- SEC-reported price per share
- $17.67
- Number of holders
- 10
- Value change
- +$1,200,542
- Number of buys
- 5
- Number of sells
- 4
- Shares outstanding
- 705,983,417
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2025
Institutions
10
Top holders
10
PHAR full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2026
Previous quarter: Q3 2025
Pharming Group N.V. SEC filings
Pharming Group N.V. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 71716E105
Recent filing periods:
Ownership snapshot
Top reported holders of PHAR - Pharming Group N.V. - Ordinary Shares / American Depositary Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
MORGAN STANLEY
Disclosed value leader
MORGAN STANLEY
Comparable rows
8/8
Latest evidence
30 Sep 2025
13D/G
13F
Lead comparable stake: 1.2%
13D/G row: MORGAN STANLEY
Showing 1-6 of 8 holder rows.
Quick read
MORGAN STANLEY leads the comparable SEC ownership view at 1.2%.
8 of 8 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens MORGAN STANLEY's linked filing trail.
Comparable ownership
Top 5
MORGAN STANLEY
1.2%
Silverberg Bernstein Capital Mana...
0.01%
EverSource Wealth Advisors, LLC
0%
Nalls Sherbakoff Group, LLC
0%
NewEdge Advisors, LLC
0%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 8 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| MORGAN STANLEY |
13D/G
13F
Company
|
1.2%
|
$70,739,538
8,471,801 shares
|
$0 | 31 Mar 2025 |
| Silverberg Bernstein Capital Management LLC |
13F
Company
|
0.01%
|
$756,132
52,147 shares
|
— | 30 Sep 2025 |
| EverSource Wealth Advisors, LLC |
13F
Company
|
0%
|
$19,967
1,377 shares
|
— | 30 Sep 2025 |
| Nalls Sherbakoff Group, LLC |
13F
Company
|
0%
|
$12,615
870 shares
|
— | 30 Sep 2025 |
| NewEdge Advisors, LLC |
13F
Company
|
0%
|
$3,671
253 shares
|
— | 30 Sep 2025 |
| BNP PARIBAS FINANCIAL MARKETS |
13F
Company
|
0%
|
$1,450
100 shares
|
— | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
10
Shares
140,452
Rows available
10
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
8
Q4 2025 holders
10
Holder diff
2
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend